The U.S. Federal Trade Commission (FTC) has approved Aurobindo Pharma’s proposed acquisition of Pennsylvania-based generic pharmaceutical firm Lannett Company.Valued at $250 million on a cash-free, debt-free basis and inclusive of normalised working capital, the transaction is expected to close be...
Liking and disliking news Highlights will help Daily News Highlights to understand visitor interests and top trends as per the user behavior hence this feature requires visitor to Sign In, if you are not registered yet, please Sing Up to personalize your reading.